Vertex Pharmaceuticals, Inc. (VRTX)
461.14
+19.06
(+4.31%)
USD |
NASDAQ |
Jan 21, 16:00
465.49
+4.35
(+0.94%)
After-Hours: 05:42
Vertex Pharmaceuticals Research and Development Expense (TTM): 3.954B for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Pfizer Inc. | 10.13B |
| Amgen, Inc. | 6.828B |
| Eli Lilly & Co. | 12.56B |
| Merck & Co., Inc. | 14.26B |
| Alnylam Pharmaceuticals, Inc. | 1.248B |